Original Research

Published on 28 Jan 2019

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

in Pharmacogenetics and Pharmacogenomics

Sara Redenšek
Dušan Flisar
Maja Kojović
Milica Gregorič Kramberger
Dejan Georgiev
Zvezdan Pirtošek
Maja Trošt
Vita Dolžan

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00008

8,187 views
36 citations

Original Research

Published on 11 Dec 2018

Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications

in Pharmacogenetics and Pharmacogenomics

Fazhong He
Yan Shu
Xingyu Wang
Xin Liu
Guojing Liu
Zhangren Chen
Zhenmin Wang
Ling Li
Rong Liu
Honghao Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01422

2,808 views
7 citations

Review

Published on 04 Dec 2018

Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data

in Pharmacogenetics and Pharmacogenomics

Yitian Zhou
Kohei Fujikura
Souren Mkrtchian
Volker M. Lauschke

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01437

9,050 views
53 citations

Review

Published on 04 Dec 2018

Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit

in Pharmacogenetics and Pharmacogenomics

Shuqin Zhou
Debra J. Skaar
Pamala A. Jacobson
R. Stephanie Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01436

45,389 views
15 citations

Original Research

Published on 03 Dec 2018

Genetic Interaction Between Two VNTRs in the SLC6A4 Gene Regulates Nicotine Dependence in Vietnamese Men

in Pharmacogenetics and Pharmacogenomics

Gea Kõks
Ele Prans
Ha Diep Thi Tran
Ngoc Bich Thi Ngo
Linh Nhat Nguyen Hoang
Hue Minh Thi Tran
Thanh Cao Ngoc
Thuoc Doan Phuoc
Xuan Dung Ho
Binh Ho Duy

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01398

3,751 views
8 citations

Review

Published on 22 Nov 2018

Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development

in Pharmacogenetics and Pharmacogenomics

Dominik D. Kaltenbach
Dinesh Jaishankar
Meng Hao
Jacob C. Beer
Michael V. Volin
Umesh R. Desai
Vaibhav Tiwari

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01315

4,699 views
19 citations

Case Report

Published on 15 Nov 2018

Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma

in Pharmacogenetics and Pharmacogenomics

Lisa M. Velez-Velez
Caren L. Hughes
Pashtoon Murtaza Kasi

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01309

4,422 views
8 citations

Original Research

Published on 14 Nov 2018

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients

in Pharmacogenetics and Pharmacogenomics

Antony Brayan Campos-Salazar
Fabiana Dalla Vecchia Genvigir
Claudia Rosso Felipe
Helio Tedesco-Silva
José Medina-Pestana
Gabriela Vieira Monteiro
Rodrigo de Gouveia Basso
Alvaro Cerda
Mario Hiroyuki Hirata
Rosario Dominguez Crespo Hirata

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01296

3,303 views
7 citations

Review

Published on 10 Oct 2018

Inhibitors of DNA Methyltransferases From Natural Sources: A Computational Perspective

in Pharmacogenetics and Pharmacogenomics

Fernanda I. Saldívar-González
Alejandro Gómez-García
David E. Chávez-Ponce de León
Norberto Sánchez-Cruz
Javier Ruiz-Rios
B. Angélica Pilón-Jiménez
José L. Medina-Franco

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01144

11,069 views
35 citations

Original Research

Published on 04 Oct 2018

A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

in Pharmacogenetics and Pharmacogenomics

Elena De Mattia
Eva Dreussi
Marcella Montico
Sara Gagno
Chiara Zanusso
Luca Quartuccio
Salvatore De Vita
Michela Guardascione
Angela Buonadonna
Mario D’Andrea

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01101

3,673 views
4 citations

Systematic Review

Published on 27 Sep 2018

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

in Pharmacogenetics and Pharmacogenomics

Zulfan Zazuli
Susanne Vijverberg
Elise Slob
Geoffrey Liu
Bruce Carleton
Joris Veltman
Paul Baas
Rosalinde Masereeuw
Anke-Hilse Maitland-van der Zee

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01111

8,325 views
36 citations

Original Research

Published on 19 Sep 2018

Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease

in Pharmacogenetics and Pharmacogenomics

He Li
Yan-Jiao Zhang
Mu-Peng Li
Xiao-Lei Hu
Pei-Yuan Song
Li-Ming Peng
Qi-Lin Ma
Jie Tang
Wei Zhang
Xiao-Ping Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01039

3,387 views
9 citations

Original Research

Published on 19 Sep 2018

Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

in Pharmacogenetics and Pharmacogenomics

Dario Kringel
Mari A. Kaunisto
Catharina Lippmann
Eija Kalso
Jörn Lötsch

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01008

3,897 views
3 citations

Mini Review

Published on 06 Aug 2018

miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer

in Pharmacogenetics and Pharmacogenomics

Kha Wai Hon
Nadiah Abu
Nurul-Syakima Ab Mutalib
Rahman Jamal

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00846

4,597 views
27 citations

Original Research

Published on 17 Jul 2018

A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis

in Pharmacogenetics and Pharmacogenomics

Marina Kawaguchi-Suzuki
Kenneth Cusi
Fernando Bril
Yan Gong
Taimour Langaee
Reginald F. Frye

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00752

5,355 views
24 citations

Original Research

Published on 23 May 2018

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients

in Pharmacogenetics and Pharmacogenomics

Letícia C. Tavares
Leiliane R. Marcatto
Renata A. G. Soares
Jose E. Krieger
Alexandre C. Pereira
Paulo C. J. L. Santos

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00542

3,606 views
17 citations

Navigation group

Articles

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications

Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data

Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit

Genetic Interaction Between Two VNTRs in the SLC6A4 Gene Regulates Nicotine Dependence in Vietnamese Men

Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development

Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients

Inhibitors of DNA Methyltransferases From Natural Sources: A Computational Perspective

A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease

Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer

A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients